YB-1 is a Transcription/Translation Factor that Orchestrates the Oncogenome by Hardwiring Signal Transduction to Gene Expression

por Wu, Joyce, Stratford, Anna L., Astanehe, Arezoo, Dunn, Sandra E.
Publicado 2007

Inhibition of RSK with the novel small-molecule inhibitor LJI308 overcomes chemoresistance by eliminating cancer stem cells

por Davies, Alastair H., Reipas, Kristen, Hu, Kaiji, Berns, Rachel, Firmino, Natalie, Stratford, Anna L., Dunn, Sandra E.
Publicado 2015

Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells

por Stratford, Anna L, Fry, Christopher J, Desilets, Curtis, Davies, Alastair H, Cho, Yong Y, Li, Yvonne, Dong, Zigang, Berquin, Isabelle M, Roux, Philippe P, Dunn, Sandra E
Publicado 2008

YB-1 evokes susceptibility to cancer through cytokinesis failure, mitotic dysfunction, and HER2 amplification

por Davies, Alastair H., Barrett, Irene, Pambid, Mary Rose, Hu, Kaiji, Stratford, Anna L., Freeman, Spencer, Berquin, Isabelle M., Pelech, Steven, Hieter, Philip, Maxwell, Christopher, Dunn, Sandra E.
Publicado 2011

Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a...

por Stratford, Anna L, Habibi, Golareh, Astanehe, Arezoo, Jiang, Helen, Hu, Kaiji, Park, Eugene, Shadeo, Ashleen, Buys, Timon PH, Lam, Wan, Pugh, Trevor, Marra, Marco, Nielsen, Torsten O, Klinge, Uwe, Mertens, Peter R, Aparicio, Samuel, Dunn, Sandra E
Publicado 2007